Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

IXJvsJDOCETF Comparison

ETF 1
IXJ

iShares Global Healthcare ETF

This fund is part of
Global Large Cap
+2.36%
VS
ETF 2
JDOC

JPMorgan Healthcare Leaders ETF

This fund is part of
Global Blended Cap
+2.31%

iShares Global Healthcare ETF (IXJ) belongs to the Global Large Cap segment. JPMorgan Healthcare Leaders ETF (JDOC) is part of the Global Blended Cap segment. IXJ's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Consumer Cyclicals. In contrast, JDOC's top sector exposures are Healthcare, Consumer Non-Cyclicals  IXJ is less expensive with a Total Expense Ratio (TER) of 0.4%, versus 0.65% for JDOC. IXJ is up 4.9% year-to-date (YTD) with -$530M in YTD flows. JDOC performs better with 5.87% YTD performance, and -$34K in YTD flows. Run a side-by-side ETF comparison of IXJ and JDOC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

IXJ vs JDOC performance and flow charts

Performance

-1.00.01.02.03.04.0%Jun 30Jul 8Jul 15Jul 22Jul 29

Cumulative Flows

050,000,000100,000,000150,000,000200,000,000Jun 30Jul 8Jul 15Jul 22Jul 29

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/30/2026
1M3MYTD1Y3Y5Y
Perf.
IXJ
JDOC
+2.87%+1.71%
+9.83%+10.10%
+4.90%+5.87%
+20.30%+23.40%
+23.01%n/a
+26.12%n/a
Flows
IXJ
JDOC
+$175M-
+$199M-$3M
-$530M-$34K
-$281M-$34K
-$520M-
+$195M-
Volatility and drawdown
3M1Y3Y5Y
Volatility
IXJ
JDOC
+17.32%+17.44%
+15.40%+15.07%
+13.91%n/a
+14.35%n/a
Max drawdown
IXJ
JDOC
-3.91%-3.99%
-10.83%-9.66%
-18.04%n/a
-18.04%n/a
Max drawdown duration
IXJ
JDOC
22d22d
122d154d
490dn/a
490dn/a
Trading data

Create an account to view trading data

Join for free
IXJ
JDOC
Last sale
7/31/2026 at 1:30 PM
$100.26
$60.64
Previous close
07/30/2026
$101.24
$61.37
Consolidated volume
07/30/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

JDOC
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
IXJ
JDOC
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/31/2026 at 1:30 PM
Live
Closed
IXJ
JDOC
Last price
$100.26
$60.64
1D performance
-0.97%
-1.19%
AuM$4.13 B$9.19 M
E/R0.4%0.65%
Characteristics
IXJ
JDOC
Management strategyPassiveActive
ProvideriSharesJ.P. Morgan Asset Management
BenchmarkS&P Global 1200 Health Care (Sector) Capped Index-
N° of holdings11061
Asset class--
Trailing 12m distribution yield
Join
Join
Inception dateNovember 13, 2001November 1, 2023
ESGNoNo
Advertisement
Exposure

Countries

IXJ
USA
69.49%
Switzerland
10.37%
Other
20.14%
JDOC
USA
75.5%
Other
24.5%

Sectors

IXJ
Healthcare
96.99%
Other
3.01%
JDOC
Healthcare
96.8%
Other
3.2%

Diversification

IXJ

Total weight of top 15 holdings out of 15

57.47%
JDOC

Total weight of top 15 holdings out of 15

60.84%

Top 15 holdings

Data as of June 30, 2026
IXJ
Eli Lilly & Co.
10.92%
Johnson & Johnson
7.04%
AbbVie, Inc.
5.12%
UnitedHealth Group, Inc.
4.39%
Merck & Co., Inc.
4.12%
AstraZeneca PLC
3.77%
Roche Holding AG
3.76%
Novartis AG
3.73%
Amgen, Inc.
2.54%
Thermo Fisher Scientific, Inc.
2.42%
Abbott Laboratories
2.05%
Gilead Sciences, Inc.
2.03%
Novo Nordisk A/S
1.99%
Intuitive Surgical, Inc.
1.83%
Pfizer Inc.
1.78%
JDOC
Eli Lilly & Co.
7.79%
AbbVie, Inc.
7.78%
UnitedHealth Group, Inc.
6.36%
Johnson & Johnson
4.83%
Merck & Co., Inc.
4.75%
AstraZeneca PLC
4.18%
Thermo Fisher Scientific, Inc.
3.36%
CVS Health Corp.
3.20%
Bristol Myers Squibb Co.
3.10%
Abbott Laboratories
2.81%
Roche Holding AG
2.73%
Novo Nordisk A/S
2.69%
GSK Plc
2.52%
argenx SE
2.50%
Intuitive Surgical, Inc.
2.24%
Frequently asked questions about IXJ and JDOC

How have the IXJ and JDOC ETFs performed in 2026?

As of July 30, 2026, IXJ is up 4.9% year-to-date (YTD), while JDOC has returned 5.87%. That puts JDOC better performer ahead so far this year.

Which ETF is attracting more investor money: IXJ or JDOC?

Year-to-date, the IXJ ETF saw -$530M in flows, compared to -$34K for JDOC.

Which ETF is more volatile: IXJ or JDOC?

Over the past year, IXJ had a volatility of 15.4%, while JDOC experienced 15.07%.

Which ETF is bigger: IXJ or JDOC?

As of July 30, 2026, IXJ holds $4.13 B in assets under management (AUM), while JDOC manages $9.19 M.

What sectors do the IXJ and JDOC ETFs invest in?

IXJ leans toward sectors like Healthcare. Meanwhile, JDOC focuses on Healthcare.

What are the top holdings of the IXJ ETF and JDOC ETF?

IXJ top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. JDOC holds in its top three: Eli Lilly & Co., AbbVie, Inc. and UnitedHealth Group, Inc..

Which ETF is more diversified: IXJ or JDOC?

IXJ holds 111 securities with 57.47% of its assets in the top 15. JDOC has 61 securities and a top 15 weight of 60.84%.

Advertisement
Latest news about IXJ & JDOC
Advertisement
Advertisement
Advertisement
Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey and get exclusive early access to the final report.

Global ETF Survey 2026